Business Standard

Pharma export growth in FY20 down to single digit due to Covid: Pharmexcil

Export growth started declining in February and turned negative in March, at -23.24 per cent

medicines, pharmacy, pharma industry
Premium

Indian pharma exports during February and March are usually quite brisk, and reach 22-23 per cent in the first ten months of the financial year

BS Reporter Hyderabad
The drop in exports in February and March has dragged pharmaceutical export growth down to a single digit of 7.57 per cent to $20.58 billion in the year 2019-20, according to the Pharmaceutical Exports Promotion Council of India (Pharmexcil). 

Indian pharma exports stood at $19.13 billion in FY19, up 10.72 per cent over the previous year.

Pharmexcil data showed export growth started declining in February, registering a 7.7 per cent increase as compared to an average monthly export growth of 11.5 per cent during the previous ten months. The figure turned negative in March, a -23.24 per cent.

ALSO READ: 

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in